Histone cluster 2 family member, designated as H2al1c, plays a pivotal role in chromatin structure and gene regulation. To comprehend the inhibition of this protein, we can scrutinize a range of chemical inhibitors that target different aspects of its function. Trifluoperazine, for instance, directly interferes with H2al1c by binding to its active site. This interaction disrupts the protein's capacity to interact with DNA and modulate histone modifications, leading to functional inhibition. The structural alterations induced by trifluoperazine hinder the protein's crucial role in chromatin remodeling, which is integral for gene expression and regulation.
In addition to direct inhibitors like trifluoperazine, various chemicals indirectly affect H2al1c through related pathways and cellular processes. Tubastatin A, a selective HDAC inhibitor, can indirectly inhibit H2al1c by influencing histone deacetylation and chromatin structure. By targeting HDACs, it modifies histone acetylation patterns, ultimately impacting H2al1c's function in chromatin remodeling and gene transcription. Similarly, Rapamycin, known to target mTOR, can regulate protein translation and indirectly influence H2al1c by affecting downstream processes crucial for gene regulation. These examples demonstrate the versatility of chemical inhibitors in targeting H2al1c, both directly and indirectly, highlighting the intricate interplay between chromatin biology and gene regulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trifluoperazine Dihydrochloride | 440-17-5 | sc-201498 sc-201498A | 1 g 5 g | $57.00 $101.00 | 9 | |
Trifluoperazine directly inhibits H2al1c by binding to its active site, disrupting histone interactions and gene regulation. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D indirectly inhibits H2al1c through RNA synthesis interference, disrupting gene transcription and protein function. | ||||||
Tubastatin A | 1252003-15-8 | sc-507298 | 10 mg | $114.00 | ||
Tubastatin A indirectly inhibits H2al1c by targeting HDACs, altering histone acetylation, and affecting chromatin structure. | ||||||
Bleomycin | 11056-06-7 | sc-507293 | 5 mg | $275.00 | 5 | |
Bleomycin indirectly inhibits H2al1c by disrupting DNA structure and synthesis, impacting gene regulation and protein activity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid indirectly inhibits H2al1c by targeting HDACs, leading to altered histone acetylation and chromatin structure changes. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG can indirectly inhibit H2al1c by modulating signaling pathways related to histone cluster function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin indirectly inhibits H2al1c by targeting mTOR, influencing protein translation and gene regulation processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 indirectly inhibits H2al1c by targeting p38 MAPK, which interacts with H2al1c, leading to functional inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 indirectly inhibits H2al1c by targeting PI3K, disrupting the PI3K/AKT pathway, which regulates H2al1c activity. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil indirectly inhibits H2al1c through interference with RNA synthesis, disrupting gene transcription and function. | ||||||